New-onset atrial fibrillation in seropositive rheumatoid arthritis: association with disease-modifying anti-rheumatic drugs treatment.

Kim, Hyung Woo; Han, Minkyung; Jung, Inkyung; Ahn, Sung Soo

Kim, Hyung Woo; Han, Minkyung; Jung, Inkyung; Ahn, Sung Soo.

Afiliación

Kim HW; Department of Internal Medicine, College of Medicine, Institute of Kidney Disease Research, Yonsei University, Seoul, Republic of Korea.
Han M; Biostatistics Collaboration Unit, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.
Jung I; Division of Biostatistics, Department of Biomedical Systems Informatics, Yonsei University College of Medicine, Seoul, Republic of Korea.
Ahn SS; Division of Rheumatology, Department of Internal Medicine, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin, Republic of Korea.

Rheumatology (Oxford) ; 63(3): 630-638, 2024 Mar 01.

Article en En | MEDLINE | ID: mdl-37421392

Asunto(s)

Antirreumáticos; Artritis Reumatoide; Fibrilación Atrial; Femenino; Masculino; Humanos; Fibrilación Atrial/epidemiología; Antirreumáticos/efectos adversos; Artritis Reumatoide/complicaciones; Artritis Reumatoide/tratamiento farmacológico; Artritis Reumatoide/epidemiología; Leflunamida; Metotrexato/uso terapéutico

Palabras clave

DMARD; RA; atrial fibrillation; risk; seropositive

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Artritis Reumatoide / Fibrilación Atrial / Antirreumáticos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Rheumatology (Oxford) Asunto de la revista: REUMATOLOGIA Año: 2024 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google